Skip to main
OHI

OHI Stock Forecast & Price Target

OHI Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 11%
Hold 67%
Sell 0%
Strong Sell 0%

Bulls say

Omega Healthcare Investors Inc. is demonstrating a robust financial outlook with an increased 2025 funds from operations (FFO) estimate, rising to $2.81 per share from $2.78 per share, driven by higher-than-expected investment volumes. Additionally, the company's normalized FFO estimate has also been adjusted upward to $2.95 per share from $2.89 per share, following the exclusion of certain non-recurring items. Furthermore, the stock has shown strong performance year-to-date, appreciating by 12% compared to the 4% increase of the broader VNQ index, while trading near the higher end of its 10-year valuation range, indicating solid investor confidence.

Bears say

The financial outlook for Omega Healthcare Investors Inc. remains unfavorable due to ongoing challenges faced by operators in the healthcare facility sector, which could impact occupancy and revenue generation. Despite an upward revision in the 2026 adjusted funds from operations (FFO) estimate from $3.13 per share to $3.22 per share, this figure still reflects only a slight improvement over the consensus core FFO estimate of $3.10 per share as reported by FactSet. Additionally, the company's relative valuation metrics do not inspire confidence, making it difficult to adopt a positive perspective on its future performance.

OHI has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 11% recommend Buy, 67% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omega Healthcare Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omega Healthcare Investors (OHI) Forecast

Analysts have given OHI a Buy based on their latest research and market trends.

According to 9 analysts, OHI has a Buy consensus rating as of Feb 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $46.22, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $46.22, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omega Healthcare Investors (OHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.